253 related articles for article (PubMed ID: 8533277)
41. Bovine babesiosis: protection of cattle with culture-derived soluble Babesia bovis antigen.
Smith RD; James MA; Ristic M; Aikawa M; Vega y Murguia CA
Science; 1981 Apr; 212(4492):335-8. PubMed ID: 7209532
[TBL] [Abstract][Full Text] [Related]
42. Identification of novel immune correlates of protection against acute bovine babesiosis by superinfecting cattle with
Bastos RG; Laughery JM; Ozubek S; Alzan HF; Taus NS; Ueti MW; Suarez CE
Front Immunol; 2022; 13():1045608. PubMed ID: 36466866
[TBL] [Abstract][Full Text] [Related]
43. Babesia bovis merozoite surface protein-2c (MSA-2c) contains highly immunogenic, conserved B-cell epitopes that elicit neutralization-sensitive antibodies in cattle.
Wilkowsky SE; Farber M; Echaide I; Torioni de Echaide S; Zamorano PI; Dominguez M; Suarez CE; Florin-Christensen M
Mol Biochem Parasitol; 2003 Apr; 127(2):133-41. PubMed ID: 12672522
[TBL] [Abstract][Full Text] [Related]
44. Prospects for recombinant vaccines against Babesia bovis and related parasites.
Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
[TBL] [Abstract][Full Text] [Related]
45. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection.
Moubri K; Kleuskens J; Van de Crommert J; Scholtes N; Van Kasteren T; Delbecq S; Carcy B; Précigout E; Gorenflot A; Schetters T
Vet Parasitol; 2018 Jan; 249():21-29. PubMed ID: 29279083
[TBL] [Abstract][Full Text] [Related]
46. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
[No Abstract] [Full Text] [Related]
47. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
[No Abstract] [Full Text] [Related]
48. Application of PCR assays to determine the genotype of Babesia bovis parasites isolated from cattle with clinical babesiosis soon after vaccination against tick fever.
Bock RE; Lew AE; Minchin CM; Jeston PJ; Jorgensen WK
Aust Vet J; 2000 Mar; 78(3):179-81. PubMed ID: 10860157
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of different heterologous prime-boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen.
Jaramillo Ortiz JM; Molinari MP; Gravisaco MJ; Paoletta MS; Montenegro VN; Wilkowsky SE
Vaccine; 2016 Jul; 34(33):3913-9. PubMed ID: 27269058
[TBL] [Abstract][Full Text] [Related]
50. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle.
Brown WC; Palmer GH; McElwain TF; Hines SA; Dobbelaere DA
Exp Parasitol; 1993 Aug; 77(1):97-110. PubMed ID: 8344411
[TBL] [Abstract][Full Text] [Related]
51. Babesia bovis: comparison of culture-derived parasites, non-living antigen and conventional vaccine in the protection of cattle against heterologous challenge.
Timms P; Dalgliesh RJ; Barry DN; Dimmock CK; Rodwell BJ
Aust Vet J; 1983 Mar; 60(3):75-7. PubMed ID: 6347164
[TBL] [Abstract][Full Text] [Related]
52. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro.
Mangold AJ; Vanzini VR; Echaide IE; de Echaide ST; Volpogni MM; Guglielmone AA
Vet Parasitol; 1996 Feb; 61(3-4):345-8. PubMed ID: 8720572
[TBL] [Abstract][Full Text] [Related]
53. Identification of conserved peptides containing B-cell epitopes of Babesia bovis AMA-1 and their potential as diagnostics candidates.
Barreda D; Hidalgo-Ruiz M; Hernandez-Ortiz R; Ramos JA; Galindo-Velasco E; Mosqueda J
Transbound Emerg Dis; 2020 Jul; 67 Suppl 2():60-68. PubMed ID: 31231975
[TBL] [Abstract][Full Text] [Related]
54. Live and soluble antigens for cattle protection to Babesia bigemina.
Echaide IE; de Echaide ST; Guglielmone AA
Vet Parasitol; 1993 Dec; 51(1-2):35-40. PubMed ID: 8128585
[TBL] [Abstract][Full Text] [Related]
55. Cocktail Babesia bovis antigens for global detection of Babesia bovis infection in cattle.
El-Sayed S; Rizk MA; Terkawi M; Igarashi I
Exp Parasitol; 2019 Nov; 206():107758. PubMed ID: 31521628
[TBL] [Abstract][Full Text] [Related]
56. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection.
Brown WC
Vet Parasitol; 2001 Nov; 101(3-4):233-48. PubMed ID: 11707299
[TBL] [Abstract][Full Text] [Related]
57. Vaccination against bovine babesiosis.
De Vos AJ; Bock RE
Ann N Y Acad Sci; 2000; 916():540-5. PubMed ID: 11193669
[TBL] [Abstract][Full Text] [Related]
58. Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens.
Figueroa JV; Precigout E; Carcy B; Gorenflot A
Ann N Y Acad Sci; 2006 Oct; 1081():382-96. PubMed ID: 17135542
[TBL] [Abstract][Full Text] [Related]
59. A common high molecular weight antigen of Babesia bovis isolates from Mexico.
Sahagun Ruiz A; Waghela SD; Romany MM; Holman PJ; Melendy D; Cruz D; Wagner GG
Int J Parasitol; 2000 Jan; 30(1):59-64. PubMed ID: 10675745
[TBL] [Abstract][Full Text] [Related]
60. Investigations of breakdowns in protection provided by living Babesia bovis vaccine.
Bock RE; de Vos AJ; Kingston TG; Shiels IA; Dalgliesh RJ
Vet Parasitol; 1992 Jun; 43(1-2):45-56. PubMed ID: 1496802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
